PDI, a provider of commercialization services to the
biopharmaceutical industry, has named Peter Tilles president of its TVG
Marketing Research and Consulting unit. Tilles is also a co-founder—and
currently serves on the board of directors—of MedAvante, Inc., a pharmaceutical
R&D services company conducting centralized assessments for mood disorder
clinical trials.